DIABETES MELLITUS TYPE 2

This study tested a new online version of a diabetes self-management program called eDECIDE. It was designed to teach problem-solving skills to help African American adults manage their type 2 diabetes day-to-day. Researchers compared the online program to a traditional in-person…

This study tested whether a new weekly injection called NNC0519-0130 could help people with type 2 diabetes better control their blood sugar and lose weight. About 300 participants received different doses of the injection or a comparison treatment for 40 weeks. Researchers measu…

This study tested a culturally adapted diabetes support program designed specifically for Latinx patients. The program used technology and behavioral strategies to help patients better manage their diabetes through education and self-care support. Researchers worked with 20 Spani…

This study observed how well the diabetes medication Xultophy works in everyday medical practice. Researchers followed 244 adults with type 2 diabetes in Japan for about 6 months after their doctor prescribed Xultophy. The study measured changes in blood sugar levels and tracked …

This study observed how well the once-daily pill Rybelsus (oral semaglutide) works for managing type 2 diabetes in everyday medical practice in Japan. It followed 650 adults for 8-10 months to see how the medication affected their blood sugar levels and body weight, while also tr…

This study tested a new automated insulin delivery system for people with diabetes who also have advanced kidney disease or are on dialysis. The goal was to see if this 'artificial pancreas' system could better control blood sugar levels compared to usual care. Fifteen participan…

This study tested whether adding a new experimental medicine (NNC0480-0389) to an existing diabetes drug (semaglutide) works better than either drug alone. 500 adults with type 2 diabetes received weekly injections of different drug combinations for about 41 weeks to find the mos…

This study tested a new phone-based program called GODART that uses artificial intelligence and game-like rewards to help people with type 2 diabetes manage their condition. It was designed specifically for rural areas where access to regular healthcare coaching can be limited. T…

This small, completed study tested if a clinical trial could be run remotely to find the best personalized drug plan for protecting the kidneys of people with type 2 diabetes. Twelve participants tried a drug called empagliflozin at home, and based on their kidney test results, s…

This study tested whether adding trained community health workers to regular clinic care helps people in rural Mexico better manage their diabetes and high blood pressure. Researchers followed 168 adults over time to see if this approach improved how consistently people took thei…

This study tested whether using a wireless continuous glucose monitor (CGM) could help hospital staff better manage blood sugar for patients with type 1 or high-risk type 2 diabetes. The CGM sent real-time data to a specialized nurse who worked with the care team to try to keep p…

This study tested a new, faster-acting insulin (faster aspart) against a standard insulin (NovoRapid®) in adults with type 1 or type 2 diabetes. Over 300 participants took four daily injections of one of the insulins, combined with a long-acting insulin, for about 7 months. The m…

This study tested a computer tool called PREVENT, designed to help homecare nurses decide which patients need their first visit most urgently after leaving the hospital. It involved nearly 2,000 patients with conditions like heart failure and diabetes. The goal was to see if usin…

This study aimed to understand how the diabetes medication semaglutide might help protect the kidneys in people who have both type 2 diabetes and chronic kidney disease. Over one year, 106 participants received either semaglutide or a placebo injection weekly. Researchers used de…

This study observed how well the oral medication Rybelsus (semaglutide) works for people with type 2 diabetes in everyday life in Saudi Arabia. Researchers followed 194 adults for 8-10 months to see if the pill helped lower blood sugar and body weight. The goal was to collect rea…

This study tested whether using mobile monitoring devices and getting support from nurses could help people better manage their type 2 diabetes and high blood pressure. It involved 220 adults whose conditions were not well controlled with standard clinic care. Researchers compare…

This study tested whether a 12-week remote program combining a very low-calorie diet with digital health tools could help people with type 2 diabetes lose significant weight and potentially achieve remission. It compared this program to standard medical care. The goal was to see …

This study tested the safety and effects of weekly semaglutide injections in 104 Chilean adults with type 2 diabetes over 24 weeks. Participants received injections and were monitored for side effects, blood sugar control, and weight changes. The goal was to understand how well t…

This study tested whether a special online tool, called 'My Diabetes Care,' added to a patient's existing health portal could help them manage type 2 diabetes better than standard care. About 458 adults with type 2 diabetes were randomly assigned to use the new tool or continue w…

This 16-week study tested whether following a low-fat vegan diet could help people with type 2 diabetes better control their blood sugar and improve their body's response to insulin. Twenty-six participants received weekly online nutrition classes and dietitian support. Researche…

This study tested a new once-weekly combination injection called IcoSema against a new once-weekly insulin (icodec) in people whose type 2 diabetes was not well controlled with daily insulin shots. Over 1,200 participants were randomly assigned to receive one of the two injection…

This study tested whether a new oral medicine called semaglutide helps children and teenagers better manage their type 2 diabetes when added to their current treatment. For about 15 months, 132 young people aged 10-17 either took semaglutide or a placebo pill, alongside their usu…

This study observed people with type 2 diabetes whose blood sugar was not well-controlled on their current medication (DPP4i). It tracked what happened when their doctor switched them to a different pill called oral semaglutide. Researchers measured changes in blood sugar, weight…

This study monitored over 3,000 Japanese patients with type 2 diabetes for about 3 years after their doctor prescribed them Ozempic (semaglutide). The goal was to track the long-term safety of the medication and see how well it controlled blood sugar and weight in everyday use. R…

This study tested whether a comprehensive, year-long community support program could help people with type 2 diabetes manage their condition better than standard medical care alone. About 98 participants in Galveston were assigned to receive either standard care or the new progra…

This study tested whether adding mindfulness training to standard diet education helps people with type 2 diabetes stick to a low-carbohydrate eating plan. Researchers worked with 60 participants to see if learning mindfulness skills—like noticing cravings without acting on them—…

This study compared two different exercise programs to see which works better for people with Type 2 diabetes. Fifty participants followed either a circuit training program or a traditional strength training program for six weeks. Researchers measured how each program affected he…

This study tested whether a new once-weekly injection called IcoSema works as well as standard daily insulin injections for controlling blood sugar in adults with type 2 diabetes. About 680 participants who weren't getting good enough control with their current daily insulin were…

This study tested whether taking daily vitamin D3 or prebiotic (inulin) supplements for six months could improve markers of heart disease risk in people with type 2 diabetes. About 190 participants were randomly assigned to receive either the real supplements or placebo pills and…

This study tested whether a special indoor lighting system could help people with Alzheimer's disease and type 2 diabetes. Researchers wanted to see if this non-drug light treatment could improve sleep, mood, and blood sugar control by helping reset the body's natural daily rhyth…

This study analyzed real-world medical records to compare two diabetes medications, tirzepatide and semaglutide, in people who also have a specific type of heart failure. Researchers looked at over 28,000 adults with type 2 diabetes and heart failure to see which drug was better …

This study tested whether two simple exercise programs could help people with type 2 diabetes. Researchers compared a specific foot-ankle exercise routine, a walking program, and standard education to see which best improved foot nerve health, stress, and quality of life over 12 …

This study compared two different add-on medications for people with type 2 diabetes whose blood sugar wasn't well controlled on their current two-drug therapy. About 133 participants in South Korea were randomly assigned to add either pioglitazone or dapagliflozin to their exist…

This study tested whether a daily probiotic supplement could improve blood vessel function and reduce markers of inflammation in people with coronary artery disease or type 2 diabetes. Researchers enrolled 215 participants to see if changing gut bacteria could help control heart …

This study observed how the diabetes medication Rybelsus (oral semaglutide) works for people with type 2 diabetes in everyday medical practice. Researchers followed 155 adults in Israel for 8-10 months to see how the once-daily pill affected their blood sugar levels and body weig…

This study tested whether personalized text messages, sent by a smart computer program, could help people with type 2 diabetes remember to take their daily pills. Researchers compared these tailored messages to generic ones to see which was better at improving medication habits a…

This small study tested whether eating house cricket powder before a sugary drink could help control blood sugar spikes in people with type 2 diabetes. Twenty participants on metformin tried cricket powder, whey protein, or a placebo mixed into soup. Researchers measured their bl…

This study tested if providing special meals designed for diabetes and nutrition coaching via video calls could help people with poorly controlled type 2 diabetes. Researchers compared these supports to usual medical care to see if they improved blood sugar levels, weight, and qu…

This study observed 50 adults with type 2 diabetes in Finland who were prescribed the oral medication Rybelsus® (semaglutide) by their doctor. Researchers tracked their blood sugar levels and weight over 8-10 months to see how the medication works in everyday life, outside of a c…

This study tested a new endoscopic procedure that aims to regenerate the lining of the small intestine to help control type 2 diabetes. Researchers enrolled 20 adults whose diabetes wasn't well-controlled on 2-3 non-insulin medications. The main goal was to check if the procedure…

This study tested the safety of Lyumjev, a fast-acting insulin, in 150 Indian adults with type 2 diabetes. Participants used the insulin for 26 weeks while researchers monitored for low blood sugar events and other side effects. The main goal was to understand how safe this insul…

This study compared the diabetes pill RYBELSUS® (oral semaglutide) to other common diabetes pills in real-world medical settings. It involved 1,020 adults with type 2 diabetes whose blood sugar wasn't well controlled on metformin alone. Participants were randomly assigned to rece…

This study tested if adding the drug dapagliflozin to the common diabetes medication metformin helps people with severe obesity and either prediabetes or type 2 diabetes lose more weight. It involved 160 participants who were randomly assigned to take either metformin alone or th…

This study tested if using a short-term insulin pump along with different oral diabetes pills could lead to better long-term blood sugar control in people newly diagnosed with type 2 diabetes. It involved 264 participants who had not yet taken any diabetes or cholesterol medicati…

This study tested if a new insulin taken just once a week works as well and is as safe as a standard insulin taken once daily. It involved nearly 1,000 adults with type 2 diabetes who were not yet using insulin. The goal was to see if the weekly option could control blood sugar l…

This study tested if giving people with type 2 diabetes a small weekly grocery allowance, on top of healthy eating advice, helps them control their blood sugar better. It focused on nearly 600 adults who struggle to afford healthy food. The goal was to see if this financial suppo…

This study tested whether a simple, at-home foot exercise program could improve blood flow in the legs of people with type 2 diabetes. Forty-four adults with diabetes were split into two groups: one did the special foot exercises daily for three months, while the other did their …

This study tested a new, higher weekly dose (7.2 mg) of the injectable medication semaglutide to see if it helps people with obesity and type 2 diabetes lose more weight and better control their blood sugar than a lower dose or a placebo. Over 500 adults participated for about 1.…

This study tested an experimental drug called AZD5004 in adults with type 2 diabetes. It aimed to see if the drug could help lower long-term blood sugar levels and reduce body weight compared to a placebo. The trial involved 406 participants and was designed to check the medicine…

This study looked back at medical records to see if a special high-protein nutritional drink (Resource® Diabet Plus) helped adults with type 2 diabetes who were malnourished or at risk of malnutrition. It involved 59 patients in Spain and checked if the drink improved their blood…

This study tested whether taking a daily probiotic supplement could help people with type 2 diabetes better manage their condition. For 12 weeks, 77 adults either took a multi-strain probiotic or continued their usual care. Researchers measured if the probiotics improved blood su…

This study monitored the safety and effectiveness of Xultophy, a combination diabetes medication, in routine medical practice. About 750 adults with type 2 diabetes in Korea who were prescribed Xultophy by their doctors were observed for 26 weeks. The research aimed to see how we…

This study observed how well the daily pill Rybelsus (oral semaglutide) worked for adults with type 2 diabetes in real-world Spanish clinics. Researchers tracked 465 patients for 8-10 months to see changes in blood sugar levels, body weight, and how satisfied people were with the…

This study tested if a new insulin, injected just once a week, works as well and is as safe as a standard daily insulin for people with type 2 diabetes. Over 580 participants, who were already using multiple daily insulin injections, were randomly assigned to receive either the w…

This study tested a new way to help vulnerable patients manage type 2 diabetes within their regular primary care clinic. The clinic offered dedicated diabetes care days with a team of providers who also addressed food insecurity, housing concerns, mental health, and exercise barr…

This study observed how well a mobile app called 'Dose Check' helped people with type 2 diabetes manage their insulin (Tresiba) in everyday life. About 179 participants in Saudi Arabia used the app for 6-7 months to get support with their correct insulin dose. The main goal was t…

This study observed how the diabetes medication Rybelsus (oral semaglutide) works for adults with type 2 diabetes in everyday medical practice. Researchers followed 145 patients in the Netherlands for 8-10 months to see how the treatment affected their blood sugar levels and body…

This study tested whether a 6-month online mindfulness course could help adults with uncontrolled type 1 or type 2 diabetes better manage their blood sugar levels. Researchers compared the mindfulness program to a standard stress management education course, with both delivered i…

This study tested whether delivering healthy food directly to the homes of people with type 2 diabetes in rural areas could help them manage their condition better. It involved 415 adults who reported having trouble getting enough healthy food. Researchers compared the health of …

This small study tested a single injection derived from umbilical cord stem cells in 12 men with severe, long-term erectile dysfunction that did not improve with standard medication (sildenafil/Viagra). The main goals were to check if the injection was safe and to see if it could…

This study tested if a diabetes medicine (semaglutide) made with a new manufacturing process works the same as the currently available version. About 388 adults with type 2 diabetes received weekly injections of one version or the other for 28 weeks. Researchers primarily checked…

This study tested whether a new weekly insulin injection, combined with a continuous glucose monitor, could effectively control blood sugar in people with type 2 diabetes who hadn't used insulin before. Participants wore a small sensor on their arm to track glucose levels continu…

This study looked back at medical records of 209 Thai adults with type 2 diabetes to see how well the oral medication semaglutide worked in everyday clinical practice. Researchers checked if the drug helped control blood sugar levels and body weight over 6 to 12 months of treatme…

This study looked at whether weight-loss surgery (sleeve gastrectomy) could improve the health of the pancreas, kidneys, and heart in young people (ages 12-21) with type 2 diabetes. Researchers measured organ function in about 50 participants before and after surgery to understan…

This study observed 336 UK adults with type 2 diabetes who were prescribed the once-daily pill Rybelsus (oral semaglutide) by their doctor. The goal was to see how well the medication worked in everyday life to lower blood sugar and body weight over 8-10 months. Researchers colle…

This study observed how the diabetes medication Rybelsus® (oral semaglutide) worked for adults with type 2 diabetes in everyday Mexican clinics. Over 8-10 months, researchers tracked changes in participants' blood sugar levels and body weight. The goal was to see how well the onc…

This study tested whether adding a weekly injection called semaglutide could allow people with type 2 diabetes to use less daily insulin while still controlling their blood sugar. Researchers compared two approaches over 11 months in 568 overweight adults: one group received the …

This study tested whether a health coaching program designed with input from immigrant communities works better than standard care to help people manage type 2 diabetes. Researchers compared the two approaches over 12 months in 202 first-generation immigrants with diabetes. The g…

This study observed 458 Italian adults with type 2 diabetes who were prescribed the once-daily pill Rybelsus (oral semaglutide) by their doctor. Researchers tracked their blood sugar control and weight changes over 8-10 months to see how the medication works in everyday practice.…

This study followed 194 adults with type 2 diabetes in Canada who were prescribed oral semaglutide (Rybelsus) by their doctors. Researchers tracked how well the medication controlled blood sugar and affected weight over 8-10 months in everyday medical practice. The study aimed to…

This study observed 99 adults with type 2 diabetes in Denmark who were prescribed the once-daily pill Rybelsus® (oral semaglutide) by their doctor. The goal was to see how well the medication worked in everyday life to lower blood sugar and body weight over 8-10 months. Researche…

This small pilot study tested whether providing uninsured Black and Hispanic patients with continuous glucose monitors and access to a clinical pharmacist could help them better manage their type 2 diabetes. The goal was to see if this combined support could improve blood sugar c…

This study tested whether a new weekly injection called semaglutide could help people with overweight or obesity manage their weight. About 375 participants were randomly assigned to receive either the real injection or a placebo for about a year, alongside lifestyle counseling. …

This study tested if giving two weekly injectable medicines, cagrilintide and semaglutide, together works better for controlling type 2 diabetes than either medicine alone. About 92 adults with type 2 diabetes participated for about 9 months. The main goal was to see if the combi…

This study tested whether a smartphone app and a small device attached to an Ozempic pen could help people with type 2 diabetes continue their weekly injection treatment. About 300 participants who were already prescribed Ozempic were involved. The goal was to see if this digital…

This study looked at whether a common type of diabetes medication, called SGLT2 inhibitors, can improve liver health in people with type 2 diabetes. Researchers measured liver stiffness and fat using special ultrasounds and blood tests in 67 patients before and after 6 months of …

This study tested how a new investigational drug called CagriSema, which combines two medicines, affects how the body uses insulin in people with type 2 diabetes. For about 42 weeks, 158 participants took either CagriSema, one of its components, or a placebo, along with their usu…

This study tested whether combining telephone-delivered diabetes education with home blood sugar monitoring could help African American adults with poorly controlled type 2 diabetes. Researchers enrolled 200 participants to see if this culturally tailored, technology-supported ap…

This study tested whether intermittent fasting (eating only during specific time windows) could improve how the pancreas works in people with early type 2 diabetes. Researchers enrolled 51 adults recently diagnosed with diabetes to see if this eating pattern could help the pancre…

This study tested a smartphone-based system designed to help adults with type 2 diabetes who are starting insulin. The system uses an algorithm to suggest insulin dose adjustments based on daily blood sugar readings, which are sent from a smart glucose meter. Researchers compared…

This large, completed study tested if higher doses (25 mg and 50 mg) of a once-daily diabetes pill called semaglutide work better than the standard 14 mg dose. Over 1,600 adults with type 2 diabetes took one of the three doses daily for 68 weeks. The main goal was to see which do…

This study tested whether a support program could help low-income African Americans with diabetic kidney disease who face challenges like food or housing insecurity. Fifty participants were randomly assigned to receive either the full program—which included education, help meetin…

This study tested three different approaches to help older adults with type 2 diabetes improve their health: a specific exercise routine, a plant-based Mediterranean diet, and a diabetes medication. One hundred inactive participants aged 65 and over were assigned to one of these …

This study tested whether a daily colostrum supplement could help people with type 2 diabetes better manage their condition. Researchers compared the supplement to a placebo in 80 Iraqi adults, some with diabetes and some healthy, over 60 days. They measured effects on blood suga…

This study tested whether treating binge eating disorder (BED) could also help improve type 2 diabetes. Researchers worked with 34 adults who had both conditions, providing them with therapy focused on changing eating behaviors. They measured changes in binge eating episodes, blo…

This large, completed study aimed to see if the type 2 diabetes medication semaglutide (taken as a daily pill) could reduce the risk of major heart problems like heart attacks and strokes. It involved over 9,600 participants aged 50+ who had type 2 diabetes and a history of heart…

This study tested whether a diabetes drug called dapagliflozin could improve heart health in people with kidney failure who need regular dialysis. Researchers gave 220 patients either the drug or a placebo pill daily for six months to see if it reduced heart muscle thickening, a …

This study tested whether a new once-weekly insulin injection works as well as standard daily insulin injections for controlling blood sugar in people with type 2 diabetes. Over 1,000 participants who were not yet using insulin were randomly assigned to receive either the weekly …

This study tested if sending personalized weekly text messages could help people with type 2 diabetes who use insulin. The messages gave advice based on the person's continuous glucose monitor data and their mood. Researchers compared 46 people who got the messages to those who d…

This study tested a medication called tirzepatide in children and teenagers (ages 10-17) whose type 2 diabetes was not well-controlled with standard treatments like metformin or insulin. Over 60 weeks, researchers compared the drug to a placebo to see if it could better lower blo…

This study tested ways to get more people with type 2 diabetes to attend helpful education classes. Researchers first tried sending reminder alerts to doctors to refer patients. Then, they tested if connecting patients with a peer who also has diabetes made them more likely to at…

This early-stage study tested a new weekly injection called NNC0519-0130 for people with obesity, with or without type 2 diabetes. Researchers wanted to see if the medicine was safe, how it moved through the body, and if it could help with weight loss and blood sugar control. The…

This study followed 194 adults with type 2 diabetes in Sweden who were prescribed the once-daily pill Rybelsus (oral semaglutide) by their doctors. The goal was to see how well the medication worked in everyday life to lower blood sugar levels and affect body weight over 8-10 mon…

This study tested if a new insulin, injected just once a week, works as well and is as safe as a standard insulin that is injected once daily. Over 500 adults with type 2 diabetes who were already using insulin participated. The main goal was to see if the weekly insulin controll…

This study tested a program to help people with type 2 diabetes who struggle to afford healthy food. For 12 weeks, researchers delivered boxes of diabetes-friendly food and easy-to-understand education materials directly to participants' homes. The goal was to see if this direct …

This study tested three different doses of a weekly injection called semaglutide in people with type 2 diabetes who were also overweight. The main goal was to see how well each dose controlled blood sugar levels and helped with weight loss over 40 weeks. Participants, who were al…

This study tested a new, non-invasive device called GLUCUBE designed to measure blood sugar levels without the pain of finger-prick tests. It involved 52 adults with type 2 diabetes and compared the GLUCUBE's readings to those from a standard glucometer. The main goal was to see …

This study aimed to see if two simple blood tests (called eLIFT and FibroMeter) could accurately screen for advanced liver scarring (fibrosis) in people with type 2 diabetes. It involved 722 participants with type 2 diabetes and a higher body weight. The results of the blood test…

This study tested a diabetes prevention program specifically designed for college students at risk of developing type 2 diabetes. Eighty UCLA students participated in a program focused on lifestyle coaching, healthy eating, and physical activity over nine months. Researchers comp…

This study tested a 6-month training program for mothers and their children in rural Mexico. The goal was to teach families about healthy eating and physical activity to prevent future heart disease and type 2 diabetes. Researchers measured changes in weight, activity levels, and…

This study tested whether a family-focused virtual coaching program could help rural adults at risk for heart disease and type 2 diabetes. Over 500 participants from rural Kentucky were randomly assigned to receive the lifestyle coaching either alone or with a family member. The …

This study tested if a simple program could help prevent type 2 diabetes in Hispanic teenagers with obesity. Researchers gave 43 teens a Fitbit and sent them encouraging text messages for 12 weeks to help them move more and sleep better. The main goal was to see if this tech-base…

This study tested whether a weekly injectable diabetes medicine called semaglutide could help people with type 2 diabetes and leg artery disease walk farther with less pain. Nearly 800 participants were randomly assigned to receive either semaglutide or a placebo injection for ab…

This study tested whether mindfulness training could help reduce stress, anxiety, and depression in people living with type 2 diabetes. Researchers worked with 140 participants, randomly assigning half to receive mindfulness sessions and half to a comparison group. They measured …

This is a long-term observational study that has been tracking the health of members of the Gila River Indian Community since 1965. The purpose is to understand what causes Type 2 diabetes and its complications, like heart and eye problems. Eligible community members receive regu…

This study looked at whether people should temporarily stop taking certain diabetes and weight loss medications before an upper endoscopy. Researchers wanted to see if pausing these drugs reduces leftover food and liquid in the stomach, which can increase the risk of breathing pr…

This study aimed to better understand and diagnose insulin allergies, a rare but serious problem where a person's body reacts badly to the insulin they need to manage diabetes. Researchers worked with 55 adults who had diabetes—some with insulin allergies and some without—to test…

This study aimed to better understand how type 2 diabetes develops and progresses in children, teenagers, and young adults. Researchers compared 82 young people with diabetes to healthy peers, measuring how their bodies process sugar, store fat, and handle exercise. The goal was …

This study aimed to understand why people of Black African or Caribbean heritage have a higher risk of developing type 2 diabetes. Researchers compared how quickly a sugary drink left the stomach in 30 White European and 30 Black African/Caribbean volunteers without diabetes. The…

This study aimed to understand how a heart failure drug called Entresto (ARNI/LCZ 696) affects the body's kidney and hormone responses to a saltwater fluid challenge. It involved 72 people with type 2 diabetes, some with and some without very early signs of heart stiffness. The m…

This study did not give any medicine to participants. Instead, researchers used health insurance records from over 150,000 people with type 2 diabetes to see if real-world data can confirm the heart safety results of a previous major trial. That trial found the injectable diabete…

This research study aimed to understand if viruses in pregnant women, especially those with diabetes, might increase the risk of heart defects in their babies. Researchers analyzed blood and stool samples from 114 women to look for viruses and the body's immune response to them. …

This study aimed to better understand how early diabetic eye disease progresses. Researchers followed 202 people with Type 2 diabetes and mild eye changes for two years. They used advanced, non-invasive eye scans to identify specific patterns that signal a higher risk of the dise…

This study aimed to understand how the approved diabetes medication semaglutide affects two specific types of cells in people with type 2 diabetes. Researchers tested whether the drug could improve the health and function of cells that repair blood vessels and cells found in fat …

This study aimed to understand why some people develop type 2 diabetes by looking at genetic and environmental factors. Researchers enrolled 1,759 adults to measure their body composition, insulin function, and glucose tolerance, and collected tissue and DNA samples. The goal was…

This study measured how quickly a new, faster-acting insulin gets into the bloodstream compared to a standard insulin. It involved 23 Chinese adults with type 1 or type 2 diabetes. Each participant received one injection of each insulin type, and researchers took frequent blood s…

This study did not test a new treatment. Instead, researchers used real-world health insurance records from over 11,000 people to try to replicate the results of a major heart failure drug trial. The goal was to see if analyzing everyday patient data can be a reliable way to answ…

This study aimed to understand if using insulin affects breathing strength and recovery after exercise in people with type 2 diabetes. Researchers compared 70 adults with diabetes, grouping them by whether they used insulin or not. Everyone completed breathing tests and a walking…

This study aimed to find the right dose of a fatty acid infusion that causes a mild, temporary state of insulin resistance in healthy volunteers. Nine healthy people received fat infusions while their bodies' response to insulin was carefully measured. The goal was to establish a…

This study used health insurance records from over 58,000 people to see if real-world data can reliably answer the same questions as a formal clinical trial. It focused on patients with type 2 diabetes and a specific type of heart failure, comparing the outcomes of those taking t…

This study tested whether attending different amounts of a diabetes education program affects how well people manage their condition and their emotional well-being. Researchers worked with 120 people with type 2 diabetes, dividing them into groups that received 100%, 60%, 10%, or…

This early-stage study aimed to see if an experimental drug for type 2 diabetes changes how the body processes a common birth control pill. Researchers also checked if the drug affects how quickly the stomach empties. The study involved 47 healthy postmenopausal women who took th…